India’s First COVID-19 Vaccine Covaxin’s Human Trials To Begin In AIIMS-Patna

New Delhi : India’s first possible COVID vaccine ‘Covaxin’ developed by Bharat Biotech is all set to go under human trail in AIIMS (All India Institute of Medical Sciences)-Patna.

The Indian Council of Medical Research (ICMR) had selected 12 medical institutes across the nation including AIIMS-Patna and AIIMS-Delhi to conduct the human trials of ‘Covaxin’.

According to reports, AIIMS-Patna will start the clinical trials on the selected 18 volunteers who have been chosen among many people. They are between the age of 18 to 55.

All the 18 selected volunteers will undergo a complete medical check-up and the first dose of ‘Covaxin’ will be given only to those volunteers whose reports turn out to be okay.

Sources said that the participants will be administered the first dose and will be kept under observation for two to three hours while conducting the first phase of the trial. Three doses of the vaccine will be given to the candidate to complete the trial, added the source.